Catch up on the latest clinical and regulatory long-term care news in the July edition of The Quality Digest!
View in browser
PM_verticals_headers_all

July 2023

 

The Quality Digest

The Quality Digest is a recap of content aimed at advancing clinical care and excellence and keeping you informed about the latest regulations.

clinical news

FDA Approves Two RSV Vaccines 

 

Both GSK and Pfizer recently won FDA approval for RSV vaccines and are planning to begin offering them this fall. The CDC's Advisory Committee on Immunization Practices (ACIP) met this month and, upon reviewing the available data, drafted recommendations for use of these newly approved vaccines in adults 60 and older. These recommendations are pending approval from the CDC Director and the Department of Health and Human Services. If approved, more than 55 million adults will be eligible to receive an RSV vaccine. 

READ MORE

Did You Know?: Order of Administration for Eye Drops and Inhalers

 

Because ophthalmic drugs and inhaled drugs generally work locally, order of administration can be integral when multiple products are to be administered at once. Learn more in PharMerica's new guide.

READ MORE

Onco360 Now Offering Jakafi, Ayvakit, and Epkinly

 

Onco360 recently obtained limited distribution drug access for the following products: 

 

Ruxolitinib (Jakafi®), approved for the treatment of: intermediate or high-risk myelofibrosis; polycythemia in adults with an inadequate response to or intolerant of hydroxyurea; steroid-refractory acute graft-vs-host disease in patients 12 and older; and chronic graft-vs-host disease when systemic therapy has failed in patients 12 and older. 

 

Prescribing Information for Jakafi

Ayvapritinib (Ayvakit®), approved for the treatment of: some cases of metastatic or unresectable gastrointestinal stromal tumors (GIST) in adults; advanced systemic mastocytosis in adults; and indolent systemic mastocytosis in adults.

 

Prescribing Information for Ayvakit

Epcoritamab-bysp (Epkinly™), approved for the treatment of: relapsed or refractory diffuse large B-cell lymphoma in adults and high-grade B-cell lymphoma in adults after two or more lines of systemic therapy.

 

Prescribing Information for Epkinly

 

reg updates

Compliance Cue: Expanded Psychotropic Definition

 

Updated surveyor guidance and statements from CMS about stepped-up oversight are driving increased scrutiny of psychotropics. To help facilities understand the top F-tags for this drug class, PharMerica has developed a series of Compliance Cues. This guide provides information on F758, which provides an expanded definition for this drug class and guidance on other medications used for psychotropic purposes. 

READ MORE
events
PharMerica_IlluminateHeader

Join Our Upcoming Webinars!

July 18 IDD graphic_1200x626

Improving Outcomes in I/DD: Value-Based & Home-Based Primary Care

 

Tuesday, July 18, 2023

1pm ET

 

Register Now
July 25 2023 Survey Activity Webinar Graphic

Survey Activity State by State: A Town Hall with DONs and Administrators

 

Tuesday, July 25, 2023

1pm ET

 

Register Now
MDS webinar 4 graphic 1200x675

Six Strategies for Successful Operational & Clinical Outcomes to Manage the Conversion to MDS 3.0 1.18.11

 

Tuesday, August 8, 2023

1pm ET

 

Register Now
Risk Management Dominos

Understanding Loss Risks in Assisted Living During Transitions in Care

 

Tuesday, August 22, 2023

1pm ET

 

Register Now
NADONA podcast graphic cropped June 2023

Podcast Episode 14: DONs & Administrators Working Better Together

Listen to our latest "Spoonful of Sugar" podcast, recorded LIVE from last week's NADONA National Conference, in which NADONA's Robin Arnicar and Sherrie Dornberger talk with McKnight's John O'Connor and PharMerica's TJ Griffin about strategies to generate collaboration between DONs and administrators to increase efficiency and improve outcomes. 

LISTEN NOW
PharM logo no tag - WHITE-3
Facebook
LinkedIn
Twitter

PharMerica, 805 N. Whittington Pkwy, Louisville, KY 40222, United States

Unsubscribe Manage preferences